DCF Advisers, LLC - Q4 2021 holdings

$247 Million is the total value of DCF Advisers, LLC's 73 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 32.1% .

 Value Shares↓ Weighting
VOO NewVANGUARD INDEX FDSput$28,377,00065,000
+100.0%
11.51%
ITCI SellINTRA-CELLULAR THERAPIES INC$18,790,000
+33.0%
359,000
-5.3%
7.62%
+22.2%
MU  MICRON TECHNOLOGY INC$16,534,000
+31.2%
177,5000.0%6.70%
+20.6%
QQQ NewINVESCO QQQ TRput$13,925,00035,000
+100.0%
5.65%
ABBV BuyABBVIE INC$13,448,000
+60.3%
99,318
+27.7%
5.45%
+47.3%
GOOG  ALPHABET INCcap stk cl c$12,587,000
+8.6%
4,3500.0%5.10%
-0.3%
REGN BuyREGENERON PHARMACEUTICALS$10,862,000
+12.2%
17,200
+7.5%
4.40%
+3.1%
XNCR BuyXENCOR INC$9,700,000
+29.1%
241,763
+5.1%
3.93%
+18.6%
ARGX  ARGENX SEsponsored adr$8,755,000
+16.0%
25,0000.0%3.55%
+6.5%
BAC SellBK OF AMERICA CORP$6,473,000
+1.6%
145,500
-3.0%
2.62%
-6.6%
INCY  INCYTE CORP$5,138,000
+6.7%
70,0000.0%2.08%
-1.9%
GM SellGENERAL MTRS CO$4,984,000
+5.1%
85,000
-5.6%
2.02%
-3.5%
AMD SellADVANCED MICRO DEVICES INC$4,317,000
+4.9%
30,000
-25.0%
1.75%
-3.6%
GLD BuySPDR GOLD TR$4,274,000
+15.7%
25,000
+11.1%
1.73%
+6.3%
TPB BuyTURNING PT BRANDS INC$4,229,000
-12.3%
111,926
+10.8%
1.72%
-19.4%
C BuyCITIGROUP INC$4,107,000
-10.0%
68,000
+4.6%
1.66%
-17.3%
PFE  PFIZER INC$3,838,000
+37.3%
65,0000.0%1.56%
+26.1%
ORCL BuyORACLE CORP$3,706,000
+6.3%
42,500
+6.2%
1.50%
-2.3%
GDX SellVANECK ETF TRUSTgold miners etf$3,683,000
-28.6%
115,000
-34.3%
1.49%
-34.4%
F BuyFORD MTR CO DEL$3,505,000
+86.8%
168,750
+27.4%
1.42%
+71.6%
IAU  ISHARES GOLD TRishares new$3,481,000
+4.2%
100,0000.0%1.41%
-4.3%
LLY  LILLY ELI & CO$3,107,000
+19.5%
11,2500.0%1.26%
+9.9%
ALNY BuyALNYLAM PHARMACEUTICALS INC$3,052,000
-7.6%
18,000
+2.9%
1.24%
-15.1%
PRTA  PROTHENA CORP PLC$2,964,000
-30.7%
60,0000.0%1.20%
-36.3%
AMGN BuyAMGEN INC$2,868,000
+19.9%
12,750
+13.3%
1.16%
+10.1%
AOD  ABERDEEN TOTAL DYNAMIC DIVD$2,647,000
+4.9%
259,0000.0%1.07%
-3.7%
VZ SellVERIZON COMMUNICATIONS INC$2,598,000
-51.9%
50,000
-50.0%
1.05%
-55.8%
ALT BuyALTIMMUNE INC$2,571,000
-5.0%
280,700
+17.3%
1.04%
-12.6%
GDXJ BuyVANECK ETF TRUSTjunior gold mine$2,306,000
+50.3%
55,000
+37.5%
0.94%
+38.1%
T BuyAT&T INC$2,276,000
+40.4%
92,500
+54.2%
0.92%
+28.9%
AAPL  APPLE INC$2,220,000
+25.5%
12,5000.0%0.90%
+15.2%
IMPL BuyIMPEL NEUROPHARMA INC$2,210,000
+21.0%
256,027
+70.7%
0.90%
+11.2%
SGEN  SEAGEN INC$2,087,000
-8.9%
13,5000.0%0.85%
-16.4%
BMY  BRISTOL-MYERS SQUIBB CO$2,026,000
+5.4%
32,5000.0%0.82%
-3.2%
ORCL NewORACLE CORPcall$1,962,00022,500
+100.0%
0.80%
HON NewHONEYWELL INTL INCcall$1,877,0009,000
+100.0%
0.76%
LNSR  LENSAR INC$1,676,000
-21.7%
279,7880.0%0.68%
-28.0%
MRVL  MARVELL TECHNOLOGY INC$1,531,000
+45.1%
17,5000.0%0.62%
+33.3%
SLV SellISHARES SILVER TRishares$1,452,000
-11.6%
67,500
-15.6%
0.59%
-18.8%
QCOM  QUALCOMM INC$1,372,000
+41.9%
7,5000.0%0.56%
+30.2%
AERI BuyAERIE PHARMACEUTICALS INC$1,348,000
-13.4%
192,065
+40.7%
0.55%
-20.4%
MS  MORGAN STANLEY$1,227,000
+0.9%
12,5000.0%0.50%
-7.3%
BIF  BOULDER GROWTH & INCOME FD I$1,179,000
+8.4%
83,0000.0%0.48%
-0.4%
INTC NewINTEL CORP$1,030,00020,000
+100.0%
0.42%
NOK  NOKIA CORPsponsored adr$933,000
+14.1%
150,0000.0%0.38%
+4.7%
MU NewMICRON TECHNOLOGY INCput$932,00010,000
+100.0%
0.38%
ITW  ILLINOIS TOOL WKS INC$864,000
+19.5%
3,5000.0%0.35%
+9.7%
MSFT  MICROSOFT CORP$841,000
+19.3%
2,5000.0%0.34%
+9.6%
VIR SellVIR BIOTECHNOLOGY INC$837,000
-31.3%
20,000
-28.6%
0.34%
-37.0%
NXPI  NXP SEMICONDUCTORS N V$797,000
+16.2%
3,5000.0%0.32%
+6.6%
ET BuyENERGY TRANSFER L P$774,000
+275.7%
94,000
+337.2%
0.31%
+245.1%
AZN  ASTRAZENECA PLCsponsored adr$742,000
-3.0%
12,7450.0%0.30%
-10.9%
EQ BuyEQUILLIUM INC$708,000
-44.1%
187,666
+1.1%
0.29%
-48.7%
XLP NewSELECT SECTOR SPDR TRcall$694,0009,000
+100.0%
0.28%
AMRN  AMARIN CORP PLCspons adr new$539,000
-33.9%
160,0000.0%0.22%
-39.2%
BDX SellBECTON DICKINSON & CO$503,000
-31.8%
2,000
-33.3%
0.20%
-37.2%
BOX  BOX INCcl a$485,000
+10.7%
18,5000.0%0.20%
+2.1%
ARNA  ARENA PHARMACEUTICALS INC$465,000
+56.0%
5,0000.0%0.19%
+43.2%
OVID  OVID THERAPEUTICS INC$455,000
-4.4%
141,7010.0%0.18%
-11.9%
NKTR  NEKTAR THERAPEUTICS$423,000
-24.7%
31,3000.0%0.17%
-30.6%
LIT SellGLOBAL X FDSlithium btry etf$422,000
-45.8%
5,000
-47.4%
0.17%
-50.3%
FCX  FREEPORT-MCMORAN INCcl b$417,000
+28.3%
10,0000.0%0.17%
+18.2%
DISCA SellDISCOVERY INC$376,000
-40.8%
15,990
-36.0%
0.15%
-45.7%
APTV  APTIV PLC$371,000
+10.7%
2,2500.0%0.15%
+1.4%
VIAC SellVIACOMCBS INCcl b$335,000
-32.2%
11,100
-11.2%
0.14%
-37.6%
WBA  WALGREENS BOOTS ALLIANCE INC$261,000
+11.1%
5,0000.0%0.11%
+1.9%
AIRT BuyAIR T INC$252,000
-9.0%
10,004
+3.4%
0.10%
-16.4%
NewESPERION THERAPEUTICS INC NEnote 4.000%11/1$211,000400,000
+100.0%
0.09%
LCTX SellLINEAGE CELL THERAPEUTICS IN$208,000
-5.0%
85,000
-2.3%
0.08%
-13.4%
MTNB  MATINAS BIOPHARMA HLDGS INC$156,000
-22.4%
154,5000.0%0.06%
-29.2%
APTX SellAPTINYX INC$152,000
-43.1%
57,000
-50.0%
0.06%
-47.5%
REGN NewREGENERON PHARMACEUTICALScall$126,000200
+100.0%
0.05%
OCX  ONCOCYTE CORP$26,000
-39.5%
12,1490.0%0.01%
-42.1%
ExitVELO3D INC*w exp 12/01/202$0-42,000
-100.0%
-0.03%
QTNT ExitQUOTIENT LTD$0-83,937
-100.0%
-0.09%
KIRK ExitKIRKLANDS INC$0-11,000
-100.0%
-0.09%
INCY ExitINCYTE CORPcall$0-5,000
-100.0%
-0.15%
MU ExitMICRON TECHNOLOGY INCcall$0-5,000
-100.0%
-0.16%
TBT ExitPROSHARES TR$0-30,000
-100.0%
-0.24%
BIIB ExitBIOGEN INC$0-2,000
-100.0%
-0.25%
LLY ExitLILLY ELI & COcall$0-2,500
-100.0%
-0.26%
ADMS ExitADAMAS PHARMACEUTICALS INC$0-140,000
-100.0%
-0.30%
PSFE ExitPAYSAFE LIMITEDord$0-110,000
-100.0%
-0.38%
AMZN ExitAMAZON COM INCcall$0-300
-100.0%
-0.44%
PG ExitPROCTER AND GAMBLE COput$0-7,500
-100.0%
-0.46%
BABA ExitALIBABA GROUP HLDG LTDcall$0-7,500
-100.0%
-0.49%
BABA ExitALIBABA GROUP HLDG LTDsponsored ads$0-14,500
-100.0%
-0.95%
GLD ExitSPDR GOLD TRcall$0-16,000
-100.0%
-1.16%
SPY ExitSPDR S&P 500 ETF TRcall$0-15,500
-100.0%
-2.94%
SPY ExitSPDR S&P 500 ETF TRput$0-67,500
-100.0%
-12.79%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INTRA-CELLULAR THERAPIES INC16Q3 202310.2%
MICRON TECHNOLOGY INC16Q3 20236.7%
ALPHABET INC16Q3 20235.8%
ABBVIE INC16Q3 20237.9%
REGENERON PHARMACEUTICALS16Q3 20235.5%
ARGENX SE16Q3 20236.4%
SPDR GOLD TRUST16Q3 20236.6%
XENCOR INC16Q3 20234.1%
BK OF AMERICA CORP16Q3 20235.4%
ORACLE CORP16Q3 20233.2%

View DCF Advisers, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-09
13F-HR2023-05-15
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-13
13F-HR2022-02-10
13F-HR2021-11-15

View DCF Advisers, LLC's complete filings history.

Compare quarters

Export DCF Advisers, LLC's holdings